1. Home
  2. NTR vs RMD Comparison

NTR vs RMD Comparison

Compare NTR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutrien Ltd.

NTR

Nutrien Ltd.

HOLD

Current Price

$68.73

Market Cap

34.2B

Sector

Industrials

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$193.97

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTR
RMD
Founded
2017
1989
Country
Canada
United States
Employees
N/A
10600
Industry
Agricultural Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
28.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NTR
RMD
Price
$68.73
$193.97
Analyst Decision
Buy
Buy
Analyst Count
22
10
Target Price
$75.45
$292.56
AVG Volume (30 Days)
2.7M
1.6M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.95%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.03
$10.60
Revenue Next Year
N/A
$7.41
P/E Ratio
$18.99
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$53.03
$180.27
52 Week High
$85.36
$293.81

Technical Indicators

Market Signals
Indicator
NTR
RMD
Relative Strength Index (RSI) N/A 46.90
Support Level N/A $190.25
Resistance Level N/A $197.41
Average True Range (ATR) 0.00 6.01
MACD 0.00 -0.82
Stochastic Oscillator 0.00 21.22

Price Performance

Historical Comparison
NTR
RMD

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: